To this end, in this study the expression of EHF was evaluated in a cohort of 152 prostate biopsies, including primary prostate cancers that developed metastatic lesions (PC+), primary prostate cancers that did not develop metastasis (PC−), and benign lesions (BL). This evidence concerns the gene EHF and Familial prostate cancer.